Akeso Inc Placement - Another Opportunistic Raise, Mixed past Deal but Is Relatively Small
Akeso Biopharma Inc (9926 HK) is looking to raise around US$460m from a mix of primary placement and selldown by its founders. In this note, we...
605 Views
Hansoh Pharma Placement - Somewhat Expected but Still Opportunistic
Hansoh Pharmaceutical Group (3692 HK) aims to raise around US$500m via a primary placement. In this note, we talk about the deal dynamics.
713 Views
HK Connect SOUTHBOUND Flows (To 1 Aug 2025); YUGE Net Buying on Weakness (FINANCIALS & HEALTHCARE)
SOUTHBOUND net buying was HUGE as H-shares underperformed mainland shares reasonably dramatically over the week. Biggest week of net buying for...
639 Views
Curator's Cut: China Healthcare Rally, Financial Market Infra Moves & Korea’s Equity Upswing
This ​Curator's Cut issue shows what's contributed to the Chinese healthcare sector's performance YTD, looks at some exchanges and depositories,...
658 Views
HK Short Interest Weekly: BYD, TraHK HSI ETF, Sino Biopharmaceutical
We analyzed the latest HK SFC report for aggregate short position as of Jul 25th and highlight short interest changes in BYD, TraHK HSI ETF, Sino...
389 Views